Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hans H. Osterhues"'
Autor:
Achim, Lother, Friedhelm, Beyersdorf, Hans H, Osterhues, Christoph, Bode, Tobias, Wengenmayer
Publikováno v:
BMC Cardiovascular Disorders
Background Pulseless electrical activity cardiac arrest is associated with poor outcomes and the identification of potentially reversible reasons for cardiac arrest is fundamental. Case presentation We describe the case of a 46-year-old male with the
Autor:
Michael J, Zellweger, Michael, Maraun, Hans H, Osterhues, Ulrich, Keller, Jan, Müller-Brand, Raban, Jeger, Otmar, Pfister, Thilo, Burkard, Friedrich, Eckstein, Stefanie, von Felten, Stefan, Osswald, Matthias, Pfisterer
Publikováno v:
JACC. Cardiovascular imaging. 7(10)
The purpose of this study was to evaluate prevalence, progression, treatment, and outcome of silent coronary artery disease (CAD) in asymptomatic patients with diabetes (DM) at high coronary risk.Despite the close association of diabetes and CAD, gen
Autor:
Hans-H. Osterhues
Publikováno v:
Advances in Noninvasive Electrocardiographic Monitoring Techniques ISBN: 9789401057967
Terms such as QT-Variability or Dynamic QT-Analysis are usually used in different contexts. This raises the necessity to exactly define them for the purposes of this paper. At onset of the research there were a lot of studies publishing results from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2df4f06b8fb7e47d0b482d71a08fb49a
https://doi.org/10.1007/978-94-011-4090-4_13
https://doi.org/10.1007/978-94-011-4090-4_13
Autor:
Matthias Pfisterer, Peter Buser, Hans Rickli, Marc Gutmann, Paul Erne, Peter Rickenbacher, André Vuillomenet, Urs Jeker, Paul Dubach, Hansjürg Beer, Se-Il Yoon, Thomas Suter, Hans H. Osterhues, Michael M. Schieber, Patrick Hilti, Ruth Schindler, Hans-Peter Brunner-La Rocca, for the TIME-CHF Investigators
Publikováno v:
JAMA. 301:383
It is uncertain whether intensified heart failure therapy guided by N-terminal brain natriuretic peptide (BNP) is superior to symptom-guided therapy.To compare 18-month outcomes of N-terminal BNP-guided vs symptom-guided heart failure therapy.Randomi